Bliss GVS Pharma Limited has informed the Exchange about Mr. Santosh Parab (DIN: 01622988) has completed his second and final term as an Independent Director. Consequently, he ceased to be a Director of the Company with effect from the close of business hours on May 25, 2026, and shall also cease to be a member of the Committees with effect from the same date.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Santosh Parab has completed his second and final 5-year term as an Independent Director of Bliss GVS Pharma Limited. He ceased to be a Director effective close of business hours on May 25, 2026. He was originally re-appointed to the Board on May 26, 2021, for this 5-year term. With this exit, he also ceased to be a member of all Board Committees from the same date. The Company has expressed gratitude for his valuable contribution and guidance during his tenure.
This is a routine board transition as Mr. Parab's term ended naturally. The Company will need to appoint a new Independent Director to fill the vacancy and maintain compliance with board composition requirements.